Form ARS Larimar Therapeutics, For: Dec 31
Tweet
Share
E-mailATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Larimar Therapeutics (LRMR) Reiterated at Market Outperform by Citizens
- Focus Graphite Completes Access Road Desktop Study and Selects Preferred Route for the Lac Knife Project
- Hummingbird Bioscience Wins APAC Trailblazer Award at 2026 Nebius AI Discovery Awards
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
